Ocular Therapeutix, Inc. [clinicaltrials_resource:f5f16543206dc83edef084dbea81a7ee]
collaborator [clinicaltrials_vocabulary:collaborator]
I-ZIP Ocular Bandage Pivotal Study [clinicaltrials:NCT00774228]Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [clinicaltrials:NCT01666210]Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug [clinicaltrials:NCT01800175]Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma [clinicaltrials:NCT01845038]Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [clinicaltrials:NCT02034019]Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis [clinicaltrials:NCT02062905]Second Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [clinicaltrials:NCT02089113]ReSure Sealant Device Exposure Registry [clinicaltrials:NCT02309736]ReSure Sealant Post Approval Study [clinicaltrials:NCT02310815]Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT02312544]Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis [clinicaltrials:NCT02445326]Feasibility Study Evaluating Safety and Efficacy of OTX-DP (Sustained Release Dexamethasone, 0.4mg) for Treatment of Dry Eye [clinicaltrials:NCT02468700]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
I-ZIP Ocular Bandage Pivotal Study [clinicaltrials:NCT00774228]Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [clinicaltrials:NCT01666210]Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug [clinicaltrials:NCT01800175]Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma [clinicaltrials:NCT01845038]Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [clinicaltrials:NCT02034019]Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis [clinicaltrials:NCT02062905]Second Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [clinicaltrials:NCT02089113]ReSure Sealant Device Exposure Registry [clinicaltrials:NCT02309736]ReSure Sealant Post Approval Study [clinicaltrials:NCT02310815]Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT02312544]Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis [clinicaltrials:NCT02445326]Feasibility Study Evaluating Safety and Efficacy of OTX-DP (Sustained Release Dexamethasone, 0.4mg) for Treatment of Dry Eye [clinicaltrials:NCT02468700]
source [clinicaltrials_vocabulary:source]
Ocular Therapeutix, Inc. [clinicaltrials_resource:f5f16543206dc83edef084dbea81a7ee]
Bio2RDF identifier
f5f16543206dc83edef084dbea81a7ee
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f5f16543206dc83edef084dbea81a7ee
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:f5f16543206dc83edef084dbea81a7ee
title
Ocular Therapeutix, Inc.
@en
type
label
Ocular Therapeutix, Inc. [clinicaltrials_resource:f5f16543206dc83edef084dbea81a7ee]
@en